Esperion Therapeutics (ESPR) Assets: 2018-2025
Historic Assets for Esperion Therapeutics (ESPR) over the last 8 years, with Sep 2025 value amounting to $364.0 million.
- Esperion Therapeutics' Assets rose 15.89% to $364.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $364.0 million, marking a year-over-year increase of 15.89%. This contributed to the annual value of $343.8 million for FY2024, which is 67.07% up from last year.
- According to the latest figures from Q3 2025, Esperion Therapeutics' Assets is $364.0 million, which was up 4.88% from $347.1 million recorded in Q2 2025.
- In the past 5 years, Esperion Therapeutics' Assets registered a high of $381.6 million during Q4 2021, and its lowest value of $205.8 million during Q4 2023.
- Its 3-year average for Assets is $302.9 million, with a median of $324.0 million in 2025.
- Per our database at Business Quant, Esperion Therapeutics' Assets crashed by 35.02% in 2022 and then skyrocketed by 67.07% in 2024.
- Esperion Therapeutics' Assets (Quarterly) stood at $381.6 million in 2021, then crashed by 35.02% to $247.9 million in 2022, then fell by 17.00% to $205.8 million in 2023, then spiked by 67.07% to $343.8 million in 2024, then grew by 15.89% to $364.0 million in 2025.
- Its Assets was $364.0 million in Q3 2025, compared to $347.1 million in Q2 2025 and $324.0 million in Q1 2025.